LedX: A novel blood-based early lung cancer detection approach with exceptional accuracy and robustness

LedX, a noninvasive circulating tumor DNA methylation assay, demonstrated satisfactory sensitivity and specificity for lung cancer detection; thus, the model can be implemented in various clinical settings. Thus, LedX represents a potentially simple and cost-effective tool for the early screening and diagnosis of lung cancer.